Acute abdomen as a side-effect of sodium-glucose co-transporter 2 inhibitors in diabetic patients

Br J Surg. 2021 Dec 1;108(12):e409. doi: 10.1093/bjs/znab390.

Authors

Antonia-Therese Kietaibl¹, Peter Fasching¹, Karl Glaser², Alexander H Petter-Puchner²

Affiliations

¹ Department of Fifth Internal Medicine with Endocrinology, Rheumatology and Gerontology with Outpatient Department, Clinic Ottakring, Vienna, Austria.
² Department of General, Oncological and Visceral Surgery, Clinic Ottakring, Vienna, Austria.

PMID: 34791086
DOI: 10.1093/bjs/znab390

No abstract available

Publication types

Review

MeSH terms

Abdomen, Acute / chemically induced*
Diabetes Mellitus / drug therapy
Diabetic Ketoacidosis / chemically induced
Humans
Sodium-Glucose Transporter 2 Inhibitors / adverse effects*

Substances

Sodium-Glucose Transporter 2 Inhibitors